Today’s patients want and deserve a more efficient and high-tech experience and the next generation of providers are no different. These upgrades can improve our productivity and enhance the quality of our patients’ lives. The post Disrupting Legacy Systems: Preparing for the Next Generation of Health Tech appeared first on MedCity News.
That is the title of a new paper out in Value in Health with co-authors Jaehong Kim, Jacob Fajnor, Kyi-Sin Than, Elizabeth S. Mearns , Stacey L. Kowal, Thomas Majda and Jakub P. Hlávka PhD. The abstract is below. Objectives To quantify how incorporating patient risk preferences and severity adjustments affect the value of a…
Moving forward, it’s essential for the health tech and medical fields to work together to make remote patient monitoring much more widely available and affordable for everyone across the country, with and without insurance. The post Remote Patient Monitoring Can Help Relieve Hospital Overcrowding — If Done Right appeared first on MedCity News.
The Alzheimer’s disease drugs that have reached the market in the past two years are antibodies designed to break up amyloid plaques. Vigil Neuroscience brings to Sanofi a different approach: an oral small molecule designed to activate microglia, immune cells that play a key role in brain health. The post Sanofi’s Neuro Pipeline Expands to…
Experts from BRG recently discussed the two presidential candidates’ stances on key healthcare issues, including drug pricing, Medicaid and AI. The post Where Trump & Harris Stand on Payers, AI, Drug Pricing and CMS appeared first on MedCity News.
[Sponsored] Scheduled for May 8 at 1 pm ET, the conversation will include Morgan Cheatham, head of healthcare and life sciences at Breyer Capital, Gurdane Bhutani, founder and managing partner of MBX Capital, and will be moderated by Mercury Head of Healthcare and Life Sciences Ben Kromnick. The post What Do Early Stage Life Science…
HAYA Therapeutics’ drugs hit targets in the dark genome, the part of the genome that does not code for proteins but plays a key role in regulating gene expression. With the Series A funding, the startup will enter Phase 1 with of a genetic medicine addressing fibrosis that leads to a type of heart failure….
Weapons dubbed “less lethal” are once again being used in Los Angeles, this time against people protesting the Trump administration’s immigration raids. During the 2020 protests sparked by the police killing of George Floyd, KFF Health News and USA Today documented the harm that rubber bullets and other “less lethal” projectiles can cause. Here’s what…
Preocupados por la inflación, los estadounidenses han estado atentos a precios de productos cotidianos como los huevos y la gasolina. Pero un gasto menos conocido debería causar más alarma: el aumento de las primas de los seguros médicos. Llevan años subiendo, y ahora lo están haciendo a un ritmo sin precedentes. Hay que considerar que,…
KFF and the Peterson Center on Healthcare examine market trends contributing to rising health costs and identify several potential federal and state policy issues to watch throughout 2025, including high-cost drugs, federal funding cuts, and workforce shortages.